SR-202 PPAR Antagonist: Precision Tools for Adipocyte Dif...
2025-10-18
SR-202, a selective PPARĪ³ antagonist, offers unparalleled specificity for dissecting PPAR-dependent adipocyte differentiation and macrophage polarization in metabolic and immunological models. Its robust performance in inhibiting nuclear receptor signaling positions it as a cornerstone for advanced obesity, insulin resistance, and type 2 diabetes research workflows.